FINCH THERAPEUTICS GROUP, INC. : Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

Item 2.02 Results of Operations and Financial Condition.

On May 16, 2022, Finch Therapeutics Group, Inc. (the "Company") issued a press release announcing its recent business highlights and financial results for the quarter ended March 31, 2022. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

--------------------------------------------------------------------------------

Item 7.01 Regulation FD Disclosure.

On May 16, 2022, the Company will host a conference call and live webcast to discuss updates to its development programs and other business highlights. The Company will post the presentation used during the webcast to its website. A copy of the presentation is furnished as Exhibit 99.2 in this Current Report on Form 8-K.

The information contained in this Current Report on Form 8-K, including Exhibit 99.1 and Exhibit 99.2 attached hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Exchange Act of 1934, as amended (the "Exchange Act"), and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

--------------------------------------------------------------------------------

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit                                   Description
Number
  99.1      Press Release, dated May 16, 2022  .
 99.2       Corporate Presentation, dated May 2022.
  104     Cover Page Interactive Data File (embedded within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses